2020 Annual General Meeting
Meeting Date: June 10, 2020
- Memorandum and Articles of Association of Iterum Therapeutics plc
- The Certificate of Limited Partnership of Sarissa Capital
- Audited consolidated accounts of Iterum Therapeutics plc for the year ended December 31, 2018
- Audited consolidated accounts of Iterum Therapeutics plc for the year ended December 31, 2019
- Waiver letter dated April 24, 2020 from the Irish Takeover Panel
- Consent letter dated May 7, 2020 from Davy Corporate
- Loan and Security Agreement with Silicon Valley Bank dated April 27, 2018
- Loan and Security Amendment Agreement with Silicon Valley bank dated January 16, 2020
- Underwriting Agreement entered into on May 24, 2018
- Securities Purchase entered into on January 16, 2020
- 2020 Investor Rights Agreement entered into on January 21, 2020
- Indenture (Exchangeable Notes) dated January 21, 2020
- Indenture (Royalty Linked Notes) dated January 21, 2020
- Annual Report on Form 10-K for year ended Dec 31 2019
- Proxy Statement filed with SEC on May 7, 2020